EE05159B1 - 2,2-asendatud-1,3-dioksolaanid, nende valmistamine, optiline lahutamine ning kasutamine vahehenditena - Google Patents

2,2-asendatud-1,3-dioksolaanid, nende valmistamine, optiline lahutamine ning kasutamine vahehenditena

Info

Publication number
EE05159B1
EE05159B1 EEP200300035A EEP200300035A EE05159B1 EE 05159 B1 EE05159 B1 EE 05159B1 EE P200300035 A EEP200300035 A EE P200300035A EE P200300035 A EEP200300035 A EE P200300035A EE 05159 B1 EE05159 B1 EE 05159B1
Authority
EE
Estonia
Prior art keywords
intermediates
preparation
optical resolution
dioxolanes
substituted
Prior art date
Application number
EEP200300035A
Other languages
English (en)
Estonian (et)
Inventor
Allegretti Marcello
Candida Cesta Maria
Curti Roberto
Nicolini Luca
Original Assignee
Domp S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Domp S.P.A. filed Critical Domp S.P.A.
Publication of EE200300035A publication Critical patent/EE200300035A/xx
Publication of EE05159B1 publication Critical patent/EE05159B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Holo Graphy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Glass Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Liquid Crystal Substances (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Secondary Cells (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EEP200300035A 2000-07-28 2001-07-18 2,2-asendatud-1,3-dioksolaanid, nende valmistamine, optiline lahutamine ning kasutamine vahehenditena EE05159B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001735A IT1318651B1 (it) 2000-07-28 2000-07-28 Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.
PCT/EP2001/008305 WO2002010150A1 (en) 2000-07-28 2001-07-18 2,2-disubstituted 1,3-dioxolanes as antitussive agents

Publications (2)

Publication Number Publication Date
EE200300035A EE200300035A (et) 2004-10-15
EE05159B1 true EE05159B1 (et) 2009-04-15

Family

ID=11445592

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300035A EE05159B1 (et) 2000-07-28 2001-07-18 2,2-asendatud-1,3-dioksolaanid, nende valmistamine, optiline lahutamine ning kasutamine vahehenditena

Country Status (25)

Country Link
US (1) US6916926B2 (xx)
EP (1) EP1307440B1 (xx)
JP (1) JP5015403B2 (xx)
KR (1) KR100788532B1 (xx)
CN (1) CN1216053C (xx)
AT (1) ATE290533T1 (xx)
AU (1) AU2001281992A1 (xx)
BR (1) BR0112802A (xx)
CZ (1) CZ301039B6 (xx)
DE (1) DE60109299T2 (xx)
EE (1) EE05159B1 (xx)
ES (1) ES2237589T3 (xx)
HK (1) HK1058798A1 (xx)
HU (1) HU229801B1 (xx)
IL (2) IL153502A0 (xx)
IT (1) IT1318651B1 (xx)
MX (1) MXPA02012922A (xx)
PL (1) PL206308B1 (xx)
PT (1) PT1307440E (xx)
RS (1) RS50862B (xx)
RU (1) RU2269522C2 (xx)
SI (1) SI21041B (xx)
SK (1) SK286795B6 (xx)
UA (1) UA73790C2 (xx)
WO (1) WO2002010150A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318650B1 (it) * 2000-07-28 2003-08-27 Dompe Spa 1,3-diossolani ad attivita' antitosse.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049660A (en) * 1971-06-18 1977-09-20 Delalande S.A. N-substituted derivatives of 4 (N-piperazinylmethyl) spiro dibenzocycloheptadi- (or tri-) ene-5, 2-dioxolane (1,3) their method of preparation and their application in therapeutics
IT1210639B (it) * 1981-02-25 1989-09-14 Menarini Sas Prodotto: 3(4-fenil1piperazinio-1-il)-1,2-propandiolo 3(teofillin-7-il)-1propansolfonato,utilizzabile in terapia,e relativo procedimento di fabbricazione
IT1203721B (it) * 1983-12-29 1989-02-23 Dompe Farmaceutici Spa Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono
SE449516B (sv) * 1984-10-16 1987-05-04 Skf Nova Ab Klemring med reglerbar halomkrets
IT1254452B (it) * 1992-02-14 1995-09-25 Dompe Farmaceutici Spa N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
IL111730A (en) * 1993-11-29 1998-12-06 Fujisawa Pharmaceutical Co Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
IT1318650B1 (it) * 2000-07-28 2003-08-27 Dompe Spa 1,3-diossolani ad attivita' antitosse.

Also Published As

Publication number Publication date
ITMI20001735A1 (it) 2002-01-28
CN1444579A (zh) 2003-09-24
IT1318651B1 (it) 2003-08-27
SI21041A (sl) 2003-04-30
AU2001281992A1 (en) 2002-02-13
RU2269522C2 (ru) 2006-02-10
DE60109299T2 (de) 2005-07-21
ITMI20001735A0 (it) 2000-07-28
US6916926B2 (en) 2005-07-12
EP1307440A1 (en) 2003-05-07
SK902003A3 (en) 2003-09-11
SI21041B (en) 2005-08-31
DE60109299D1 (de) 2005-04-14
EE200300035A (et) 2004-10-15
IL153502A (en) 2006-12-10
PT1307440E (pt) 2005-05-31
CZ2003269A3 (cs) 2003-06-18
CZ301039B6 (cs) 2009-10-21
KR100788532B1 (ko) 2007-12-24
US20030176446A1 (en) 2003-09-18
MXPA02012922A (es) 2003-10-06
JP2004505074A (ja) 2004-02-19
ES2237589T3 (es) 2005-08-01
HU229801B1 (en) 2014-07-28
ATE290533T1 (de) 2005-03-15
KR20030016424A (ko) 2003-02-26
YU3103A (sh) 2006-05-25
EP1307440B1 (en) 2005-03-09
SK286795B6 (sk) 2009-05-07
IL153502A0 (en) 2003-07-06
HK1058798A1 (en) 2004-06-04
WO2002010150A1 (en) 2002-02-07
PL206308B1 (pl) 2010-07-30
JP5015403B2 (ja) 2012-08-29
UA73790C2 (uk) 2005-09-15
RS50862B (sr) 2010-08-31
HUP0301473A2 (hu) 2003-08-28
PL361173A1 (en) 2004-09-20
BR0112802A (pt) 2003-07-01
CN1216053C (zh) 2005-08-24

Similar Documents

Publication Publication Date Title
ATE502932T1 (de) Makrocyclische analoga und verfahren zu ihrer verwendung und herstellung
CY1105836T1 (el) 12, 13-τροποποιημενα παραγωγα εποθιλονης
DK0776324T3 (da) Endothelin-antagonister
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
CY1107662T1 (el) Μεθοδος παρασκευης της (ε, ζ) 3-(2-aminoethoxyimino)-androstane-6,17-dione και αναλογων της
ATE288414T1 (de) Herstellung von 2-amino-2(2-(4- alkylphenyl)äthyl)propan-1,3-diolen
DE60137206D1 (de) Herstellung von fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethylether
DK1140788T3 (da) Fremgangsmåde til fremstilling af arylethere
DE50101861D1 (de) Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung
NO20030220L (no) Ny form av (R)-N-[5-metyl-8-(4-metylpiperazin-1-yl)-1,2,3,4- tetrahydro-2-naftyl]-4-morfolinobenzamid
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
EE05159B1 (et) 2,2-asendatud-1,3-dioksolaanid, nende valmistamine, optiline lahutamine ning kasutamine vahehenditena
DK1307441T3 (da) 1,3-dioxolaner med en hostehæmmende virkning
DK1086071T3 (da) Hyperforinforbindelser, anvendelse heraf og formuleringer indeholdende disse
EA200201003A1 (ru) Аморфная модификация торасемида
DE69105816D1 (de) Herstellung von Diisopropyläther.
ES2037667T3 (es) Procedimiento para la obtencion de indolinas.
EA200200741A1 (ru) Способ получения эфиров арилиминометилкарбаминовой кислоты
EA200200090A1 (ru) Способ получения замещенных бензизотиазоловых соединений

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20101231

GB1A Change in the ownership or in the address of the owner
MM4A Lapsed by not paying the annual fees

Effective date: 20160718